Intrust Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $362K | Sell |
689
-644
| -48% | -$338K | 0.03% | 311 |
|
|
2025
Q1 | $845K | Hold |
1,333
| – | – | 0.08% | 169 |
|
|
2024
Q4 | $950K | Sell |
1,333
-282
| -17% | -$201K | 0.1% | 154 |
|
|
2024
Q3 | $1.7M | Buy |
1,615
+3
| +0.2% | +$3.15K | 0.17% | 104 |
|
|
2024
Q2 | $1.69M | Sell |
1,612
-34
| -2% | -$35.7K | 0.18% | 102 |
|
|
2024
Q1 | $1.58M | Sell |
1,646
-27
| -2% | -$26K | 0.17% | 114 |
|
|
2023
Q4 | $1.47M | Buy |
1,673
+53
| +3% | +$46.5K | 0.17% | 114 |
|
|
2023
Q3 | $1.33M | Sell |
1,620
-28
| -2% | -$23K | 0.17% | 107 |
|
|
2023
Q2 | $1.18M | Buy |
1,648
+8
| +0.5% | +$5.75K | 0.14% | 128 |
|
|
2023
Q1 | $1.35M | Buy |
1,640
+108
| +7% | +$88.7K | 0.17% | 111 |
|
|
2022
Q4 | $1.11M | Buy |
1,532
+107
| +8% | +$77.2K | 0.15% | 128 |
|
|
2022
Q3 | $982K | Buy |
1,425
+172
| +14% | +$119K | 0.15% | 126 |
|
|
2022
Q2 | $741K | Buy |
1,253
+14
| +1% | +$8.28K | 0.11% | 169 |
|
|
2022
Q1 | $865K | Buy |
1,239
+223
| +22% | +$156K | 0.11% | 170 |
|
|
2021
Q4 | $641K | Buy |
1,016
+20
| +2% | +$12.6K | 0.08% | 208 |
|
|
2021
Q3 | $603K | Buy |
996
+110
| +12% | +$66.6K | 0.08% | 208 |
|
|
2021
Q2 | $495K | Buy |
886
+147
| +20% | +$82.1K | 0.07% | 231 |
|
|
2021
Q1 | $350K | Buy |
739
+303
| +69% | +$144K | 0.05% | 278 |
|
|
2020
Q4 | $211K | Buy |
436
+65
| +18% | +$31.5K | 0.03% | 343 |
|
|
2020
Q3 | $208K | Buy |
+371
| New | +$208K | 0.04% | 320 |
|